Use of cetrizine in androgenetic alopecia

Authors

DOI:

https://doi.org/10.62305/biosana.v4i4.257

Keywords:

Antihistamines, dermatology, Cetirizine, androgenetic alopecia, frontal fibrosing alopecia, alopecia areata

Abstract

When treating allergies, which could be investigated in the context of androgenetic alopecia with the aim of having evaluated its efficacy and safety as an alternative treatment that focused on determining whether cetrizine can improve the symptoms or its progression, possibly by means of modulation of the inflammatory response associated with this condition. We sought to obtain results that expanded the therapeutic options available for patients affected by this common form of hair loss. Cetirizine, through its use in the treatment of allergies, has emerged as a complementary treatment for androgenic alopecia, a form of hair loss characterized by a defined pattern of baldness in men and women. The relationship between cetirizine and androgenic alopecia has been based on its anti-inflammatory properties and its ability to modulate the immune response, which can influence the hair growth cycle. The effect of cetirizine on the inhibition of histamine, an inflammatory mediator that has also played a role in regulating the hair follicular cycle. It will be noted that cetirizine may help prevent the miniaturization of hair follicles, a key process in androgenic alopecia, by reducing local inflammation and modulating immune activity in the scalp. The use of antihistamines in dermatology has been frequent, their uses are broad and for various skin pathologies, therefore it is of interest in the field of dermatology to know the advances, frequent uses, and novelties of this group of drugs for updated clinical practice. . , the use of Cetirizine to treat alopecia, effectiveness has been demonstrated in androgenetic alopecia, frontal fibrosing alopecia, lichen planus pilaris, these being considered the same entity, alopecia areata, therefore this systematic review is carried out to obtain the most important findings in the scientific community and use in clinical practice. Since it is a well-tolerated antihistamine with an anti-inflammatory effect, it reduces PGD2 that inhibits hair growth and increases PGE2 that promotes it. Cetirizine increases PGE, inhibits PGD2 and reduces inflammatory cell infiltration making it a potential safe treatment for AGA. Cetirizine has anti-inflammatory properties and anti-allergic properties so it has fewer side effects than minoxidil. None of the patients reported a specific side effect after the application of Cetirizine

Downloads

Download data is not yet available.

References

Antonio, J. R., Antonio, C. R., & Trídico, L. A. (2017). Tratamento da alopecia androgenética: associação de laser Erbium Glass 1550nm e infiltração de ativos. Surgical & Cosmetic Dermatology, 9(1), 19-23. http://www.surgicalcosmetic.org.br/details/544/en-US/tratamento-da-alopecia-androgenetica--associacao-de-laser-erbium-glass-1550nm-e-infiltracao-de-ativos

Bassiouny, E. A., El-Samanoudy, S. I., Abbassi, M. M., Nada, H. R., & Farid, S. F. (2023). Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study. Archives of Dermatological Research, 315(5), 1293-1304. https://link.springer.com/article/10.1007/s00403-022-02512-2

Brenner, F. (2014). Alopecias não cicatriciais adquiridas. In. https://www.researchgate.net/publication/283083425_ALOPECIAS_NAO_CICATRICIAIS_ADQUIRIDAS

Carbón, Cuauhtémoc Alatorre, Cuastumal Figueroa , Chirino Rodríguez, & Rincón, O. (2022). Un enfoque clínico terapéutico para la alopecia androgenética: una descripción general. EIMEC scientific, 1(1). https://www.eimecscientific.com/wp-content/uploads/2022/02/EIMECSCIENTIFIC-Vol1-Issue1-Un-enfoque-cli%CC%81nico-terape%CC%81utico-para-la-alopecia-androgene%CC%81tica-una-descripcio%CC%81n-general.pdf

Clissold, S. P., & Heel, R. C. (1987). Topical minoxidil: a preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica. Drugs, 33, 107-122. https://link.springer.com/article/10.2165/00003495-198733020-00002

Cruz, M. E. T., & García, L. (2017). Alopecia androgenética masculina de inicio precoz asociada a cáncer de próstata. Revista de la Facultad de Ciencias Médicas (Quito), 42(2), 60-65. https://www.academia.edu/download/57904602/Revista_FCM_2017_Vol_42_N2_FINAL_aprobado.pdf#page=64

Diniz, B. B., Vital, A. S., Pedrosa, G. F. P., & Corazza, B. F. B. (2024). Revisão sistemática do uso de plasma rico em plaquetas em dermatologia estética. Journal Archives of Health, 5(3), e2137-e2137. https://ojs.latinamericanpublicacoes.com.br/ojs/index.php/ah/article/view/2137

Esguerra, M., & Engel, E. R. (2024). Fremanezumab-associated injection site alopecia. BMJ Case Reports CP, 17(8), e260741. https://casereports.bmj.com/content/17/8/e260741.abstract

Formiga, M. W. M. (2021). Estudo comparativo da eficácia de tratamentos para a alopecia androgenética por meio da técnica intradermoterapia capilar: minoxidil e finasterida. Repositório Institucional do Unifip, 6(1). https://coopex.unifip.edu.br/index.php/repositoriounifip/article/view/1269

Klobusch, J., Mössler, K., Rabe, T., & Runnebaum, B. (1990). Current approach in the diagnosis and therapy of alopecia in gynecology. Therapeutische Umschau. Revue Therapeutique, 47(12), 985-990. https://europepmc.org/article/med/2096482

Kridis, W. B., Boudawara, O., & Khanfir, A. (2024). Chemotherapy induced alopecia in breast cancer patients: A monocentric prospective study. Breast disease, 43(1), 251-255. https://pubmed.ncbi.nlm.nih.gov/39213044/

Lama, S. B. C., Pérez-González, L. A., Kosoglu, M. A., Dennis, R., & Ortega-Quijano, D. (2024). Physical Treatments and Therapies for Androgenetic Alopecia. Journal of Clinical Medicine, 13(15), 4534. https://www.mdpi.com/2077-0383/13/15/4534

Lamana, F., Malveira, M. M. H., Speranza, M. H., de Oliveira, A. M., Freitas, M. F., de Carvalho Neto, E. A., Dona, C. R. D., Duarte, I. A., Silva, W. R., & Rodrigues, E. C. d. S. R. (2022). Atualizações sobre o tratamento da alopécia androgenética em homens: Updates on the treatment of androgenetic alapécia in men. Brazilian Journal of Health Review, 5(6), 22376-22392. https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/54010

Macedo, J. L., Oliveira, A. S. d. S. S., Pereira, I. C., Assunção, F. D., Reis, E. R., & Assunção, M. d. J. S. M. (2019). Eficácia da fitoterapia no tratamento da Alopecia Androgenética. Research, Society and Development, 8(5), e285868-e285868. https://rsdjournal.org/index.php/rsd/article/view/868

Mar Cornelio, O., Cuellar Justiz, O., Vega Izaguirre, L., & Orellana García, A. (2023). Diseño curricular del programa académico de la Maestría en Informática Médica Aplicada. Revista Cubana de Informática Médica, 15(1). http://scielo.sld.cu/scielo.php?pid=S1684-18592023000100002&script=sci_arttext

Mariano, J. P. A. V., dos Santos, G. M., de Sousa Lima, M. K., Luzzani, J. M., de Carvalho Barbosa, T., de Araújo Negreiros, K. O., & Leite, C. Q. (2022). Alopecia androgenética feminina: Uma revisão de literatura. RECISATEC-REVISTA CIENTÍFICA SAÚDE E TECNOLOGIA-ISSN 2763-8405, 2(8), e28171-e28171. https://recisatec.com.br/index.php/recisatec/article/view/171

Mia, M. T. (2023). Alopecia: Updated management. Bangladesh Journal of Medicine, 137-137. https://banglajol.info/index.php/BJMED/article/view/73384

Mostafa, D. H., Samadi, A., Niknam, S., Nasrollahi, S. A., Guishard, A., & Firooz, A. (2021). Efficacy of cetirizine 1% versus minoxidil 5% topical solution in the treatment of male alopecia: a randomized, single-blind controlled study. Journal of Pharmacy & Pharmaceutical Sciences, 24, 191-199. https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31456

Nakakura, C., de Menezes, E. A., de Oliveira, F. A., Fiorese, G. S., Barcaro, K. P. P., de Lima Lopes, L., Dowsley, T. C., Pedrassani, V. H. C., Vicentini, M. C., & Conte, A. M. M. (2023). Alopecia androgenética: aspectos etiopatogênicos, métodos diagnósticos e condutas terapêuticas. Brazilian Journal of Health Review, 6(3), 12950-12964. https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/60717

Pastore, F. (2023). La fotobiomodulación como terapia para la alopecia. Dermatología Argentina, 29(1), 36-36. http://dermatolarg.org.ar/index.php/dermatolarg/article/download/2423/1336

Peng, S., Yang, Y., Man, Y., Long, D., Wang, L., Li, K., & Liu, P. (2024). Explore the genetic exposure to alopecia areata. Skin Research and Technology, 30(8), e13874. https://onlinelibrary.wiley.com/doi/abs/10.1111/srt.13874

Pereira, P. N., Corrêa, G. R., Gonçalves, I. T., Bertanha, S., & da Silva Fernandes, L. (2023). Eficácia do plasma rico em plaquetas para o tratamento de alopécia androgenética. RECIMA21-Revista Científica Multidisciplinar-ISSN 2675-6218, 4(10), e4104194-e4104194. https://recima21.com.br/index.php/recima21/article/view/4194

Sarmento, R. G. B., & Nogueira, A. P. S. (2020). Terapia Capilar da Alopecia Androgenética Masculina com o uso do Laser de Baixa Potência Associado a Óleos Essenciais. ID on line. Revista de psicologia, 14(53), 463-473. https://idonline.emnuvens.com.br/id/article/view/2824

Sharma, R. K., Sharma, D., & Sharma, R. K. (2018). Indian Dermoscopic Study of One Thirty Eight Cases of Alopecia Areata. International Journal of Innovative Research in Medical Science (IJIRMS), 3(02). https://pdfs.semanticscholar.org/aba0/a9311e1f0a8dd09e12075c00d29bf22c2b77.pdf

Sorbellini, E., Fusco, I., Madeddu, F., & Libra, M. (2023). Experience of novelty laser therapy emission with 675 nm wavelength for the treatment of androgenetic alopecia in male and female patients: A case series study. Photobiomodulation, Photomedicine, and Laser Surgery, 41(6), 265-271. https://www.liebertpub.com/doi/abs/10.1089/photob.2022.0162

Torres, H., & González-de la Parra, M. (2024). Cetirizina (antialérgico) síntesis. https://doi.org/10.13140/RG.2.2.26093.97767

Werner, B., & Mulinari-Brenner, F. (2012). Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata-part I. Anais brasileiros de dermatologia, 87, 742-747. https://www.scielo.br/j/abd/a/vpnqyvvfhNr7SD4Xz36psyc/

Yaseer, S. K., Hassan, F. J., & Suleiman, H. B. (2020). Eficacia del tratamiento con inyecciones intradérmicas de plasma rico en plaquetas para la alopecia androgenética en varones: estudio de «antes-después». Actas Dermo-Sifiliográficas, 111(7), 574-578. https://www.sciencedirect.com/science/article/pii/S0001731020301137

Zhang, G., Huang, X., Li, H., Gong, H., Zhou, Y., & Liu, F. (2024). Relationship of Hypothyroidism with Alopecia Areata and Androgenetic Alopecia: Insights from a Two-Sample Mendelian Randomization Study. Clinical, Cosmetic and Investigational Dermatology, 1865-1874. https://www.tandfonline.com/doi/abs/10.2147/CCID.S474168

Published

2024-09-10

How to Cite

Bastidas Torres, D. M. ., Brigham Samaniego, C., Villalva Niama, E. S., & Castillo Batallas, J. E. (2024). Use of cetrizine in androgenetic alopecia . BIOSANA Health Scientific Journal. ISSN 2960-8481, 4(4), 457–466. https://doi.org/10.62305/biosana.v4i4.257